Molzym has been committed to innovative solutions for biological research and diagnosis of infectious diseases. The efforts are particularly focused on new processes enabling and facilitating the molecular diagnosis and next generation sequencing (NGS) of diseases caused by bacteria and fungi. This overview discusses pre-analytical problems and solutions contributed by new tools for nucleic acid extraction and PCR amplification on microbiome research.